Serum hyaluranidase levels in patients with aneurysmal subarachnoid haemorrhage

Singapore Medical Journal

Volumn 49, Issue 5, 2008, Pages 405-409

  Isman, F ^a   Kucur, M ^b   Tanriverdi, Taner ^a,c   Kacira, T ^c   Sanus, G Z ^c   Kemerdere, R ^c   Hanimoglu, H ^c   Kaynar, M Y ^c  

^a Taksim Teaching and Research Hospital ^*  (Canada)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Aneurysm; Extracellular matrix; Hyaluronidase; Subarachnoid haemorrhage; Vasospasm

Indexed keywords

BIOLOGICAL MARKER; HYALURONIDASE; HYALURONOGLUCOSAMINIDASE;

ADULT; AGED; ANEURYSM; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HYDROCEPHALUS; MALE; PROSPECTIVE STUDY; PROTEIN DETERMINATION; STATISTICAL SIGNIFICANCE; SUBARACHNOID HEMORRHAGE; VASOSPASM; BLOOD; BRAIN VASOSPASM; CASE CONTROL STUDY; INTRACRANIAL ANEURYSM; MIDDLE AGED; TIME;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYALURONOGLUCOSAMINIDASE; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TIME FACTORS; VASOSPASM, INTRACRANIAL;

EID: 44149122816     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003; 53:123-35.
2. Grasso G. An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Brain Res Rev 2004; 44:49-63.
3. Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery 2005; 56:633-54.
4. Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 2005; 105:23-56.
5. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992; 6: 2397-404.
6. Csoka AB, Frost GI, Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix 2001; 20: 499-508.
7. Chajara A, Raoudi M, Delpech B, et al. Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats. Arterioscler Thromb Vasc Biol 2000; 20:1480-7.
8. Chajara A, Raoudi M, Delpech B, Levesque H. The fibroproliferative response of arterial smooth muscle cells to balloon catheter injury is associated with increased hyaluronidase production and hyaluronan degradation. Atherosclerosis 2001; 157:293-300.
9. George J, Stern R. Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury. Clin Chim Acta 2004; 348:189-97.
10. Neudecker BA, Stern R, Connolly MK. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma. Br J Dermatol 2004; 150:469-76.
11. Bok SW. Hyaluronidase, from wound healing to cancer (II). Med Hypotheses 1982; 8:455-9.
12. Delpech B, Chevallier B, Reinhardt N, et al. Serum hyaluronan (hyaluronic acid) in breast cancer patients. Int J Cancer 1990; 46:388-90.
13. Delpech B, Girard N, Bertrand P, et al. Hyaluronan: fundamental principles and applications in cancer. J Intern Med 1997; 24:41-8.
14. Haselsberger K, Radner H, Pendl G. Na2B12H11SH (BSH) in combination with systemic hyaluronidase: a promising concept for boron neutron capture therapy for glioblastoma. Neurosurgery 1996; 39:321-6.
15. Pillwein K, Fuiko R, Slavc I, et al. Hyaluronidase additional to standard chemotherapy improves outcome for children with malignant brain tumors. Cancer Lett 1998; 131:101-8.
16. Al Qteishat A, Gaffney JJ, Krupinski J, et al. Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain 2006; 129:2158-76.
17. Al Qteishat A, Gaffney JJ, Krupinski J, Slevin M. Hyaluronan expression following middle cerebral artery occlusion in the rat. Neuroreport 2006; 17:1111-4.
18. Yasuda T, Ribeiro LG, Maroko PR. Effect of hyaluronidase on experimental cerebral infarct size and mortality. Lab Invest 1982; 46:400-4.
19. Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16:562-72.
20. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987; 18:365-72.
21. Hirashima Y, Hayashi N, Endo S, Takaku A. Sequential changes in the platelet count in patients with symptomatic vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1993; 33:220-4.
22. Pettigrew LE, Wilson JT, Teasdale GM. Assessing disability after head injury: improved use of the Glasgow Outcome Scale. J Neurosurg 1998; 89: 939-43.
23. Natowicz MR, Wang Y. Human serum hyaluronidase: characterization of a clinical assay. Clin Chim Acta 1996; 245:1-6.
24. Evanko SP, Angello JC, Wight TN. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19:1004-13.
25. Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D. Serum levels of hyaluronic acid in patients with psoriatic arthritis. Clin Rheumatol 2000; 19:455-7.
26. Enegd B, King JAJ, Stylli S, et al. Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity. Neurosurgery 2002; 50:1311-8.